Fig. 9From: Pharmacokinetics, microscale distribution, and dosimetry of alpha-emitter-labeled anti-PD-L1 antibodies in an immune competent transgenic breast cancer modelFour sections of a tumor collected 72 h after 225Ac-DOTA-anti-PD-L1-BC antibody administration. a CD8 immunohistochemistry and b H&E stain. c Alpha-camera and d segmented high-intensity alpha-camera regions overlayed on the H&E-stained sectionBack to article page